Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

被引：0
|
作者：
Jia Peng
Ming-Ming Liu
Jing-Lu Jin
Ye-Xuan Cao
Yuan-Lin Guo
Na-Qiong Wu
Cheng-Gang Zhu
Qian Dong
Jing Sun
Rui-Xia Xu
Jian-Jun Li
机构：
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Cardiovascular Diseases, Fu Wai Hospital, National Center for Cardiovascular Diseases
来源：
Cardiovascular Diabetology | / 19卷
关键词：
PCSK9; DM; CAD; Maces; Cardiovascular metabolic markers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Elevated circulating PCSK9 level is associated with 28-day mortality in patients with sepsis: a prospective cohort study
    Shu, Yuanlu
    Deng, Ziwei
    Deng, Ye
    Zhou, Jianliang
    Wang, Jin
    Duan, Zhenxing
    Jiang, Tao
    Zhao, Xiang
    Shi, Zhihua
    Qiu, Chengfeng
    BMC EMERGENCY MEDICINE, 2023, 23 (01)
  • [42] Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study
    Jia Peng
    Ming-Ming Liu
    Hui-Hui Liu
    Yuan-Lin Guo
    Na-Qiong Wu
    Qian Dong
    Jie Qian
    Ke-Fei Dou
    Cheng-Gang Zhu
    Jian-Jun Li
    Thrombosis Journal, 19
  • [43] Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study
    Peng, Jia
    Liu, Ming-Ming
    Liu, Hui-Hui
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Dong, Qian
    Qian, Jie
    Dou, Ke-Fei
    Zhu, Cheng-Gang
    Li, Jian-Jun
    THROMBOSIS JOURNAL, 2021, 19 (01)
  • [44] Association between Lipoprotein(a) concentration and adverse cardiac events in patients with coronary artery disease: An observational cohort study
    Amin, Navaneeth
    Devasia, Tom
    Kamath, Shobha Ullas
    Paramasivam, Ganesh
    Shetty, Prasad Narayana
    Singh, Ajit
    Prakash, N. S. Ganesha
    INDIAN HEART JOURNAL, 2024, 76 (03) : 197 - 201
  • [45] Association of hemoglobin glycation index with clinical outcomes in patients with coronary artery disease: a prospective cohort study
    Wen, Zhi-Ying
    Li, Fa-Peng
    Wu, Ting-Ting
    Hou, Xian-Geng
    Pan, Ying
    Deng, Chang-Jiang
    Li, Yan-Xiao
    He, Xue-Chun
    Gao, Wei-Tong
    Chen, Hong-Xia
    Zheng, Ying-Ying
    Xie, Xiang
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [46] Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease
    Zhang, Y.
    Xu, R. -X.
    Li, S.
    Zhu, C. -G.
    Guo, Y. -L.
    Sun, J.
    Li, J. -J.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (04) : 426 - 433
  • [47] Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain
    Kammerlander, Andreas A.
    Mayrhofer, Thomas
    Ferencik, Maros
    Pagidipati, Neha J.
    Karady, Julia
    Ginsburg, Geoffrey S.
    Lu, Michael T.
    Bittner, Daniel O.
    Puchner, Stefan B.
    Bihlmeyer, Nathan A.
    Meyersohn, Nandini M.
    Emami, Hamed
    Shah, Svati H.
    Douglas, Pamela S.
    Hoffmann, Udo
    DIABETES CARE, 2021, 44 (04) : 1038 - 1045
  • [48] Ten-year cardiovascular risk in diabetes patients without of coronary artery disease - a Danish cohort study
    Olesen, K. K. W.
    Madsen, M.
    Gyldenkerne, C.
    Thrane, P. G.
    Thim, T.
    Jensen, L. O.
    Botker, H. E.
    Sorensen, H. T.
    Maeng, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3044 - 3044
  • [49] GENE EXPRESSION PROFILING OF MARKERS OF INFLAMMATION, ANGIOGENESIS, COAGULATION AND FIBRINOLYSIS IN PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH PCSK9 INHIBITORS
    Zupan, Janja
    Ugovsek, Sabina
    Likozar, Andreja Rehberger
    Hrovat, Katja
    Sebestjen, Miran
    ATHEROSCLEROSIS, 2024, 395
  • [50] Potential candidates for PCSK9 inhibitors among patients with stable coronary artery disease presumed to be on maximally tolerated hypolipidemic treatment
    Rallidis, L.
    Triantafyllis, A.
    Drosatos, A.
    Katsimardos, A.
    Kotakos, C.
    Zolindaki, M.
    Moutsatsou, P.
    Iliodromitis, E.
    EUROPEAN HEART JOURNAL, 2017, 38 : 120 - 120
12345